Abiopharma

Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026

QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention

Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates

Adamas Trust Declares First Quarter 2026 Common Stock Dividend of $0.23 Per Share, and Preferred Stock Dividends

KNOT Offshore Partners LP Announces Termination of Discussions on Proposed Buyout Offer From Knutsen NYK Offshore Tankers AS

Marvell Technology, Inc. Declares Quarterly Dividend Payment

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

SS&C Advocates for Open Governance Standards in Enterprise AI

Parsons Awarded $47M Classified Contract Extension

Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates